Home  |  About SITC  |   Twitter  |  LinkedIn  |  YouTube  |  Oncology Tube  |  Sitemap

Press Releases

2014

SITC Reacts to FDA Approval of First PD-1 Blocking Drug for Melanoma
September 5, 2014

ASCO 2014 Concludes with Additional Promising Data for the Future of Cancer Immunotherapy
June 3, 2014

More Promising Cancer Immunotherapy Data Released at ASCO for the Treatment of Patients with Melanoma and Cervical Cancer
June 2, 2014

Data Presented at the ASCO Annual Meeting Expands the Field of Cancer Immunotherapy to Treat New Cancer Types
June 1, 2014

New Video Delves into the Promise of Cancer Immunotherapy Clinical Trials for Patients with Non-Small Cell Lung Cancer
May 15, 2014

2013

New Cancer Immunotherapy Fellowship Award Announced at Society for Immunotherapy of Cancer Annual Meeting
November 9, 2013

Don't Miss Key Scientific Meetings Covering the Major Advances in Cancer Immunotherapy
October 24, 2013

SITC Consensus Statement Provides a Road Map for Treating Melanoma Patients with Cancer Immunotherapy
August 27, 2013

SITC President Part of Team Reaching Bach2 in Cancer Immunotherapy Treatment
July 1, 2013

Additional Data Released at ASCO Annual Meeting Shows More Promising Results
for Immunotherapy as a Treatment Option in Melanoma

June 2, 2013

Melanoma Patients Receive Promising News Regarding Cancer Immunotherapy
Combination Treatment

June 1, 2013

FDA Review in Journal for ImmunoTherapy of Cancer Offers New Insights into Cancer Immunotherapy Product Development & Clinical Evaluation
May 30, 2013

SITC Members Participate in Rally for Medical Research to Support Cancer Immunotherapy
April 8, 2013

The Society for Immunotherapy of Cancer Leads Worldwide Task Force to Validate Immunoscore as a new Component for the Classification of Colon Cancer
March 28, 2013

OPTiM Trial Results are First Positive Phase 3 OncologicalVirus Cancer Immunotherapy Study in Melanoma
March 22, 2013

2012

Recent Discoveries in Cancer Immunotherapy Research Offer New Hope for Cancer Patients
October 25, 2012
 

SITC Leaders Publish Landmark Studies on New Cancer Immunotherapeutics
June 2, 2012
 

2011

Researchers Honored at the Society for Immunotherapy of Cancer 26th Annual Meeting Awards Ceremony
November 7, 2011
 

New research on immune based therapies for cancer presented at the SITC 26th Annual Meeting & Associated Programs
November 4, 2011
 

FDA Approves Ipilimumab, Major Breakthrough in Cancer Immunotherapy
March 25, 2011
 

2010

NIH Awards Major Funding to Support "Cancer Immunotherapy Trials Network"
October 4, 2010
 

Leading Cancer Immunotherapy Scientists and Research Teams Honored at iSBTc Annual Meeting
October 4, 2010
 

Major Advances in Cancer Immunotherapy Highlighted at Key Scientific Meetings in Washington, D.C.
September 23, 2010
 

Cancer Immunotherapies Coming of Age 
June 8, 2010
 

Immunotherapy Breakthrough for Cancer Patient Treatment 
June 6, 2010
 

FDA Approval of New Prostate Treatment Shows Promise of Cancer Immunotherapy 
April 29, 2010
 

 

Browse the Archive

 



Society for Immunotherapy of Cancer
555 East Wells Street, Suite 1100  |  Milwaukee, WI 53202-3823 USA
Tel: +1 414 271 2456  |  Fax: +1 414 276 3349  |  Email: info@sitcancer.org
About SITC  |  Meetings  |  Membership  |  Patient/Consumer Resources  |  Professional Resources  |  Support SITC
© 2014 Society for Immunotherapy of Cancer. All rights reserved.